SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GLGC Gene Logic
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Lokness who wrote (22)1/18/1999 12:05:00 PM
From: Arthur Radley  Read Replies (1) of 360
 
Steve,
This is why I think GLGC has a great future ahead. The major drug companies NEED their expertise.

To: +TexasDude (27440 )
From: +Henry Niman Monday, Jan 18 1999 7:30AM ET
Reply # of 27442

Speaking of sub-populations, today's WSJ has a review on the Pharmaceutical Sector, emphasizing patent expirations in the next four years and a slowing growth rate. The report suggests that advances in molecular biology will drive new products which will focus on genetically defined sub-populations
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News